Abstract

The title compound, C14H15FN2O2S, crystallizes with two mol­ecules in the asymmetric unit. In each mol­ecule, the pyrimidine ring adopts a sofa conformation with the sp 3-hybridized C atom forming the flap and the fluoro-substituted ring in an axial position. In the crystal, mol­ecules are linked via N—H⋯S hydrogen bonds, forming chains of R 2 2(8) rings along [100]. In one independent mol­ecule, an intra­molecular C—H⋯O hydrogen bond is observed.

Highlights

  • The title compound, C14H15FN2O2S, crystallizes with two molecules in the asymmetric unit

  • DHPMs have recently emerged as important target molecules because of their therapeutic and pharmacological properties (Kappe, 2000), such as antiviral (Hurst & Hull, 1961), antimitotic (Mayer et al, 1999), anticarcinogenic and antihypertensive (Atwal et al, 1991)

  • The bond lengths and bond angles are in good agreement with the corresponding bond distances and angles reported in closely related structures (Qin et al, 2006; Krishnamurthy & Begum, 2015)

Read more

Summary

Introduction

The title compound, C14H15FN2O2S, crystallizes with two molecules in the asymmetric unit. The pyrimidine ring adopts a sofa conformation with the sp3hybridized C atom forming the flap and the fluoro-substituted ring in an axial position. Molecules are linked via N—H S hydrogen bonds, forming chains of R22(8) rings along [100].

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.